ici 204,219 has been researched along with Lupus Erythematosus, Systemic in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenwasser, LJ | 1 |
| Finkel, TH | 1 |
| Hunter, DJ | 1 |
| Paisley, JE | 1 |
| Finkel, RS | 1 |
| Larsen, GL | 1 |
2 other studies available for ici 204,219 and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Leukotriene modifiers: new drugs, old and new reactions.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Autoimmune Diseases; Chromones; Churg-Strauss Syndrome; Cyc | 1999 |
Drug-induced lupus in a child after treatment with zafirlukast (Accolate).
Topics: Anti-Asthmatic Agents; Asthma; Child; Female; Humans; Indoles; Leukotriene Antagonists; Lupus Erythe | 1999 |